Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion type Assertion NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_head.
- NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion description "[heterozygous and synonymous transition of the EGFR gene and low EGFR expression levels of mRNA and protein in squamous cell carcinomas of the head and neck (SCCHN) may be reliable predictors of high sensitivity in SCCHN patients to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_provenance.
- NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion evidence source_evidence_literature NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_provenance.
- NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion SIO_000772 18097577 NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_provenance.
- NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion wasDerivedFrom lhgdn-20090331 NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_provenance.
- NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_assertion wasGeneratedBy ECO_0000203 NP162318.RAdFKmOSnEBqLxFoPQq_mV2Wj3e_Hx3TlyNMNtgyH14uQ130_provenance.